Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Pharmacokinetic issues on cancer pharmacotherapy]Yusuke TanigawaraProteome Science|May 23, 2014
Forced expression of S100A10 reduces sensitivity to oxaliplatin in colorectal cancer cellsSayo Suzuki, Yusuke TanigawaraCancer Science|March 3, 2015
Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western doseHirotsugu Kenmotsu, Yusuke TanigawaraEuropean Journal of Clinical Pharmacology|July 29, 2011
Optimal dose finding of garenoxacin based on population pharmacokinetics/pharmacodynamics and Monte Carlo simulationYusuke Tanigawara, Kenji Nozawa, Hisatsugu TsudaInternational Journal of Clinical Oncology|February 25, 2005
Cancer pharmacogenomics: international trendsYasuko Yamayoshi, Emiko Iida, Yusuke TanigawaraNihon Rinsho. Japanese Journal of Clinical Medicine|January 26, 2002
[Variability in drug response caused by the genetic polymorphisms of receptors]Yusuke Tanigawara, Osamu Iketani, Yasuko YamayoshiCancer Chemotherapy and Pharmacology|September 15, 2020
Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancerTakahiro Tsushima, Hidefumi Kasai, Yusuke TanigawaraCPT: Pharmacometrics & Systems Pharmacology|January 20, 2021
Pharmacodynamic analysis of hypertension caused by lenvatinib using real-world postmarketing surveillance dataYuki Otani, Hidefumi Kasai, Yusuke TanigawaraCPT: Pharmacometrics & Systems Pharmacology|October 22, 2021
Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance dataYuki Otani, Hidefumi Kasai, Yusuke TanigawaraCPT: Pharmacometrics & Systems Pharmacology|March 31, 2026
SCOUT: An Exploratory Approach to Scouting Dose-Relevant CovariatesYasuhisa Ideno, Hidefumi Kasai, Yusuke TanigawaraPageof 10